IDEA AG   Report issue

For profit Phase 2 Phase 3
Founded: Munich Germany (1993)
Status: Left NME R&D (2018)

Organization Overview

First Clinical Trial
2004
NCT00372333
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now